What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Enzyme
His primary areas of investigation include Internal medicine, Immunology, Inflammation, Endocrinology and Atheroma.
The study incorporates disciplines such as Placebo, Surgery and Cardiology in addition to Internal medicine.
His research in Immunology intersects with topics in Endothelium and Macrophage.
His Inflammation study incorporates themes from Disease, Pathology, Immune system and CD40.
Peter Libby has included themes like Vascular disease and Intensive care medicine in his Disease study.
His study in Endocrinology is interdisciplinary in nature, drawing from both Peroxisome proliferator-activated receptor, HMG-CoA reductase, Cytokine and Cell biology.
His most cited work include:
- Inflammation and Atherosclerosis (6124 citations)
- Inflammation in atherosclerosis (5682 citations)
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (4538 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Inflammation, Immunology, Pathology and Endocrinology are his primary areas of study.
Peter Libby interconnects Placebo and Cardiology in the investigation of issues within Internal medicine.
His Cardiology research incorporates elements of Thrombosis and Rosuvastatin.
His Inflammation research includes elements of Tumor necrosis factor alpha, Disease, Vascular disease and Cell biology.
Peter Libby has researched Immunology in several fields, including Macrophage and Transplantation.
In his research on the topic of Pathology, Extracellular matrix is strongly related with Matrix metalloproteinase.
He most often published in these fields:
- Internal medicine (36.10%)
- Inflammation (23.50%)
- Immunology (22.73%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (36.10%)
- Inflammation (23.50%)
- Immunology (22.73%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Inflammation, Immunology, Myocardial infarction and Disease.
His biological study spans a wide range of topics, including Placebo, Endocrinology and Cardiology.
His study on Inflammation also encompasses disciplines like
- Pathology together with Atheroma,
- Thrombosis that intertwine with fields like Neutrophil extracellular traps and Endothelium.
His Immunology and Immune system and Monocyte investigations all form part of his Immunology research activities.
His work on Myocardial infarction is being expanded to include thematically relevant topics such as Stroke.
The study incorporates disciplines such as Risk factor and Intensive care medicine in addition to Disease.
Between 2015 and 2021, his most popular works were:
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (3050 citations)
- Clonal Hematopoiesis and risk of atherosclerotic cardiovascular disease (728 citations)
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (508 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Enzyme
Peter Libby mostly deals with Internal medicine, Inflammation, Disease, Immunology and Myocardial infarction.
Internal medicine is closely attributed to Cardiology in his research.
His Inflammation research includes themes of Innate immune system, Bone marrow, Pathology and Immunity.
His Pathology research is multidisciplinary, incorporating perspectives in Endothelium, Plaque rupture, Plaque erosion and In vivo.
The concepts of his Disease study are interwoven with issues in Ageing, Stem cell, Bioinformatics and Intensive care medicine.
His Myocardial infarction research also works with subjects such as
- Heart failure which is related to area like Macrophage,
- Thrombosis together with Endothelial stem cell and Atheroma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
